| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/05/2000 | US6114357 Hemoregulatory compounds |
| 09/05/2000 | US6114338 Heterocyclic compounds |
| 09/05/2000 | US6114333 2-Pyrimidineamine derivatives and processes for their preparation |
| 09/05/2000 | US6114328 Isoxazoline and isoxazole fibrogen receptor antagonists |
| 09/05/2000 | US6114317 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 09/05/2000 | US6114313 Mixture of nucleotide, mannitol and adjuvants |
| 09/05/2000 | US6113896 Serine protease inhibitors which inhibit factor x |
| 09/05/2000 | US6113570 Method of removing thrombosis in fistulae |
| 08/31/2000 | WO2000050639A2 Gene sequence variations with utility in determining the treatment of disease |
| 08/31/2000 | WO2000050453A1 A novel inhibitor of programmed cell death |
| 08/31/2000 | WO2000050419A1 Substituted bicyclic heterocycles and the use thereof as thrombin inhibitors |
| 08/31/2000 | WO2000050400A1 2-aminopyridines containing fused ring substituents |
| 08/31/2000 | WO2000032632A3 Allo- and auto-reactive t-cell epitopes from rhesus protein and their use |
| 08/31/2000 | WO2000028029A3 Cell surface glycoproteins |
| 08/31/2000 | WO2000028023A3 Ischaemia/reperfusion-inducible dna's and proteins |
| 08/31/2000 | WO2000027425A3 Pharmaceutical preparation containing a receptor-antagonist for treating blood-clotting disorders |
| 08/31/2000 | WO2000023465A3 Methods and reagents for isolating biologically active peptides |
| 08/31/2000 | DE19907813A1 Substituierte bicyclische Heterocyclen, deren Herstellung und deren Verwendung als Arzneimittel Substituted bicyclic heterocycles, their preparation and their use as medicaments |
| 08/31/2000 | CA2363621A1 A novel inhibitor of programmed cell death |
| 08/31/2000 | CA2362533A1 Gene sequence variations with utility in determining the treatment of disease |
| 08/30/2000 | EP1031578A2 High purity albumin production by a multistep process |
| 08/30/2000 | EP1031347A1 Transnasal transport/immunisation with highly adaptable carriers |
| 08/30/2000 | EP1030851A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 08/30/2000 | EP1030845A1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 08/30/2000 | EP1030836A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 08/30/2000 | EP1030831A1 Process for the preparation of azacycloalkylalkanoyl pseudotetrapeptides |
| 08/30/2000 | EP1030675A2 Treatment of hematologic disorders |
| 08/30/2000 | EP1030673A1 Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis |
| 08/30/2000 | EP1030661A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA 2? INHIBITORS |
| 08/30/2000 | EP1030567A1 System, method and composition for dialysis and shock treatment |
| 08/30/2000 | EP0765340B1 Methionine sulfone and s-substituted cysteine sulfone derivatives as enzyme inhibitors |
| 08/30/2000 | EP0705274B1 Method and composition for treating thrombosis |
| 08/30/2000 | EP0631501B1 Glycosylation-mediated inhibition of factor x |
| 08/30/2000 | EP0612246B1 Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| 08/30/2000 | EP0573605B1 Preparation of factor ix |
| 08/30/2000 | EP0248819B2 Recombinant fibroblast growth factors |
| 08/30/2000 | CN1265148A Anticoagulant fusion protein anchored to cell membrane |
| 08/30/2000 | CN1265098A Heterocyclic derivatives which inhibit factor XA |
| 08/30/2000 | CN1264709A Human interleukin 11 derivative without amino acids at positions No.1-No.9 of N terminal |
| 08/30/2000 | CN1264598A Gluconokinase microemulsion and preparing process thereof |
| 08/30/2000 | CN1264584A Medicine for treating craniocerebral trauma andintracranial hematoma and its preparing process |
| 08/30/2000 | CN1055843C Method for prepn. of medicine for treating aplastic anemia |
| 08/29/2000 | US6111084 Sialyl lewis mimetics produced by solid phase synthesis; antiinflammatory agents |
| 08/29/2000 | US6110947 An analgesic agent for treating stroke, abdominal pain; as antiinflammatory, diuretic, anesthetic or neuroprotective agents |
| 08/29/2000 | US6110735 Method for the preparation of a viral vector by intermolecular homologous recombination |
| 08/29/2000 | US6110721 Isolated polypeptide at least about 80% homologous to and possesses at least one immune epitope of thrombin reference amino acid sequence; anticoagulants and procoagulants; diagnosis of blood disorders; drug screening; antitumor agents |
| 08/29/2000 | US6110504 A crystalloid solution consisting of dissolved salts comprising sodium chloride, potassium chloride, calcium chloride, magnesium chloride and organic acid selected from lactate, acetate, pyruvate, gluconate, succinate, and glucose |
| 08/29/2000 | CA1341090C Vampire bat plasminogen activators |
| 08/24/2000 | WO2000049147A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
| 08/24/2000 | WO2000048996A2 β-ALANINE DERIVATIVES |
| 08/24/2000 | WO2000048635A1 Novel albumin-free factor viii formulations |
| 08/24/2000 | WO2000048625A2 Inhibitors for use in hemostasis and immune function |
| 08/24/2000 | WO2000048624A2 Utilization of orosomucoid in order to produce a pharmaceutical preparation |
| 08/24/2000 | WO2000048623A1 Novel amide derivatives as growth hormone secretagogues |
| 08/24/2000 | WO2000048602A1 Intermittent claudication therapeutic drugs comprising pyrroloazepines |
| 08/24/2000 | WO2000048592A1 Essential fatty acids in the prevention of cardiovascular events |
| 08/24/2000 | WO2000023100A9 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 08/24/2000 | WO2000015797A3 Compositions and methods for the treatment of immune related diseases |
| 08/24/2000 | WO1998000439A3 Multivalent compounds for cross-linking receptors and uses thereof |
| 08/24/2000 | DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha |
| 08/24/2000 | CA2634674A1 Novel albumin-free factor viii formulations |
| 08/24/2000 | CA2371824A1 .beta.-alanine derivatives |
| 08/24/2000 | CA2362970A1 Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy |
| 08/24/2000 | CA2362664A1 Utilization of orosomucoid in order to produce a pharmaceutical preparation |
| 08/24/2000 | CA2362290A1 Novel amide derivatives as growth hormone secretagogues |
| 08/24/2000 | CA2361273A1 Inhibitors for use in hemostasis and immune function |
| 08/24/2000 | CA2329524A1 Intermittent claudication therapeutic drugs comprising pyrroloazepines |
| 08/23/2000 | EP1029921A1 Serpin resistant chymotrpsin superfamily proteases, particularly PAI-1 resistant t-PA, complementary inhibitor mutants; compositions; genes; expressions |
| 08/23/2000 | EP1029551A2 Nitrogen monoxide metabolite-polyoxyalkylene-hemoglobin complex |
| 08/23/2000 | EP1029548A1 Method for keeping the quality of aqueous parenteral solution of thrombomodulin in storage and distribution |
| 08/23/2000 | EP1029058A1 Dna demethylase, therapeutic and diagnostic uses thereof |
| 08/23/2000 | EP1028974A1 Secreted proteins and polynucleotides encoding them |
| 08/23/2000 | EP1028971A2 Novel conjugates of rgd-containing peptides and endogenous carriers |
| 08/23/2000 | EP1028752A2 Platelet substitutes and conjugation methods suitable for their preparation |
| 08/23/2000 | EP1028717A2 Unsubstituted polydiallylamine for treating hypercholesterolemia |
| 08/23/2000 | EP0698023B1 Fibrinogen receptor antagonists |
| 08/23/2000 | CN1264377A Substituted pyrazoles as P38 kinase inhabitors |
| 08/23/2000 | CN1264376A 3(5)-Heteroaryl substituted pyrazoles as P38 kinase inhibitors |
| 08/23/2000 | CN1264375A Crystal modification of N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 08/23/2000 | CN1263778A Thrombolytic medicine |
| 08/23/2000 | CN1263770A Thrombolytic medicine and its preparing process |
| 08/23/2000 | CN1055700C Therapeutic peptide derivatives |
| 08/23/2000 | CN1055698C Tripeptide antithrombotic agents |
| 08/23/2000 | CN1055697C Phospholipi derivatives containing higher elements of the Vth main group |
| 08/23/2000 | CN1055632C Chinese patent medicine for treating colporrhagia after abortion |
| 08/22/2000 | USRE36831 Iron-pyridone complexes for anemia |
| 08/22/2000 | US6107473 Kringle-related clone HTHBZ47 |
| 08/22/2000 | US6107323 Preventing or treating angiotensin diseases by administering an antagonist and compound which increases insulin sensitivity |
| 08/22/2000 | US6107304 Anemia |
| 08/22/2000 | US6107280 Administering bactericidal/permeability-increasing protein to delay or prevent clot formation in the blood or to enhance clot dissolution in blood |
| 08/22/2000 | US6107275 Anticoagulants |
| 08/22/2000 | CA2176973C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 08/22/2000 | CA2176494C Purification of hemoglobin |
| 08/22/2000 | CA2016627C Proteinase inhibitors, process for the preparation thereof and medicaments containing these |
| 08/17/2000 | WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 08/17/2000 | WO2000047620A1 Cytokine-binding domain |
| 08/17/2000 | WO2000047602A1 33 human secreted proteins |
| 08/17/2000 | WO2000047594A1 Novel gymnemic acid derivatives, process for the preparation thereof and use thereof as medicine |
| 08/17/2000 | WO2000047575A1 Pyrrole derivatives and cell death inhibitors |
| 08/17/2000 | WO2000047573A1 Heterocyclic derivatives as inhibitors of factor xa |